HMGCR and situs inversus: When zebrafish embryos are treated with statins, which inhibit the rate-limiting enzyme HMG-CoA reductase in the cholesterol synthesis pathway, they develop ciliopathy spectrum disorders, including situs inversus and polycystic kidney (Maerz et al, 2019).